Symptoms are caused by excessive GH-secreting pituitary adenoma and craniofacial fibrous dysplasia; thus, the overall aim of treatment is to inhibit excessive GH secretion, with optimal facial esthetics following treatment. The gene discussed is GH1; the disease is pituitary gland adenoma.